Dr. Udai S Kammula, MD
Claim this profileUPMC Hillman Cancer Center
Studies Liver Cancer
Studies Biliary Tract Cancer
3 reported clinical trials
1 drug studied
Area of expertise
1Liver Cancer
Stage IV
Stage III
2Biliary Tract Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Udai S Kammula, MD is currently running
TIL Therapy
for Biliary Tract Cancer
This trial uses a special chemotherapy followed by the patient's own lab-grown immune cells and a drug to boost the immune system. It targets patients with advanced biliary tract cancers, which are difficult to treat. The process involves removing tumor cells, growing immune cells in a lab, reducing the patient's existing immune cells, and then infusing the lab-grown cells back into the patient.
Recruiting1 award Phase 210 criteria
Tumor Infiltrating Lymphocytes
for Uveal Melanoma
This is a Phase 2 study in which the efficacy of a non-myeloablative lymphodepleting preparative regimen followed by infusion of autologous TIL and high-dose aldesleukin in patients with metastatic uveal melanoma will be evaluated. Metastatic uveal melanoma (UM) carries a poor prognosis with estimated survival of 4-6 months. There are no known effective systemic therapies. Metastatic UM is classified as an "orphan" disease and there are currently few clinical trial options for these patients. Thus, novel systemic approaches are desperately needed. A recent pilot study has found that administration of autologous tumor infiltrating lymphocytes (TIL) generated from resected metastases can induce objective tumor response and durable complete response in metastatic uveal melanoma patients. These encouraging results require confirmation to determine if this immunotherapy is of future benefit in treating this disease.
Recruiting1 award Phase 220 criteria
More about Udai S Kammula, MD
Clinical Trial Related5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Udai S Kammula, MD has experience with
- Tumor Infiltrating Lymphocytes (TIL)
Breakdown of trials Udai S Kammula, MD has run
Liver Cancer
Biliary Tract Cancer
Bile Duct Cancer
Stomach Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Udai S Kammula, MD specialize in?
Udai S Kammula, MD focuses on Liver Cancer and Biliary Tract Cancer. In particular, much of their work with Liver Cancer has involved Stage IV patients, or patients who are Stage III.
Is Udai S Kammula, MD currently recruiting for clinical trials?
Yes, Udai S Kammula, MD is currently recruiting for 3 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Udai S Kammula, MD has studied deeply?
Yes, Udai S Kammula, MD has studied treatments such as Tumor Infiltrating Lymphocytes (TIL).
What is the best way to schedule an appointment with Udai S Kammula, MD?
Apply for one of the trials that Udai S Kammula, MD is conducting.
What is the office address of Udai S Kammula, MD?
The office of Udai S Kammula, MD is located at: UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania 15232 United States. This is the address for their practice at the UPMC Hillman Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.